Cytek Biosciences (CTKB) Short Interest
Nasdaq • CTKB • US23285D1090
As of Oct 27, 2026, ORTEX estimated 4.2% of free float sold short, 3.3 days to cover, cost to borrow 0.58%. Sign up for live short interest data.
Nasdaq • CTKB • US23285D1090
As of Oct 27, 2026, ORTEX estimated 4.2% of free float sold short, 3.3 days to cover, cost to borrow 0.58%. Sign up for live short interest data.
This page tracks how heavily Cytek Biosciences (Nasdaq:CTKB) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Cytek Biosciences (Nasdaq: CTKB) has a market capitalization of $756.59M. Last close $5.79 (as of 2026-11-11); 52-week range $3.31 to $6.34. ORTEX data as of 2026-10-27: short interest was 4.22% of free float, 3.3 days to cover and the average cost to borrow was 0.58%. Sign up for live short interest data.